This Sarepta Therapeutics Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• William Blair analyst Sami Corwin downgraded Sarepta Therapeutics, Inc. SRPT from Outperform to Market Perform. Sarepta Therapeutics shares closed at $20.77 on Wednesday. See how other analysts view this stock.
• JMP Securities analyst Mikhail Goberman downgraded the rating for Guild Holdings Company GHLD from Market Outperform to Market Perform. Guild Holdings shares closed at $19.72 on Wednesday. See how other analysts view this stock.
• Oppenheimer analyst Noah Kaye downgraded the rating for Johnson Controls International plc JCI from Outperform to Perform. Johnson Controls shares closed at $103.48 on Wednesday. See how other analysts view this stock.

Considering buying SRPT stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q3 Earnings

Photo via Shutterstock